• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过铜催化的点击化学反应修饰格尔德霉素,改变其与伴侣蛋白热休克蛋白 90 的亲和力和细胞毒性。

Modifications of geldanamycin via CuAAC altering affinity to chaperone protein Hsp90 and cytotoxicity.

机构信息

Faculty of Chemistry, Adam Mickiewicz University, Uniwersytetu Poznańskiego 8, 61-614, Poznań, Poland.

Unit of Biophysical Chemistry, Department of Physical Chemistry, Faculty of Chemistry, University of Lodz, Pomorska 165, Lodz, 90-236, Poland.

出版信息

Eur J Med Chem. 2023 Aug 5;256:115450. doi: 10.1016/j.ejmech.2023.115450. Epub 2023 May 12.

DOI:10.1016/j.ejmech.2023.115450
PMID:37210951
Abstract

Functionalization of alkyne (1) and azide (2) derivatives of geldanamycin (GDM) via dipolar cycloaddition CuAAC yielded 35 new congeners (3-37) with C(17)-triazole arms bearing caps of different nature (basic vs. acidic, hydrophilic vs. hydrophobic). Confrontation of biological data (anticancer activity vs. toxicity in normal cells) with lipophilicity (clogP), dissociation constants (K) of complexes with Hsp90 and binding modes to Hsp90 revealed SAR in specific subgroups of GDM derivatives. The most potent GDM congeners 14-16, bearing C(17)-triazole-benzyl-halogen arms exhibited the most optimal clogP values of 2.7-3.1 at favourable binding to Hsp90 (K at μM level). The anticancer activity of 14-16 (IC = 0.23-0.41 μM) is higher than those of GDM (IC = 0.58-0.64 μM) and actinomycin D (ActD, IC = 0.62-0.71 μM) in SKBR-3, SKOV-3 and PC-3 cell lines, with a comparable cytotoxicity in healthy cells. The relationship between structure and attractive anticancer potency (IC = 0.53-0.74 μM) is also observed for congeners with C(17)-triazole-saccharide or C(17)-triazole-unsaturated arms. In the former, the absolute configuration at C(4) (ᴅ-glucose vs. ᴅ-galactose) whereas in the latter the length of the unsaturated arm influences the cytotoxic effects due to different binding strength (K, ΔE) and modes with Hsp90. Among all triazole congeners of GDM that are biologically attractive and exhibit lower toxicity in normal cells than GDM and ActD, the derivative 22, bearing the C(17)-triazole-cinnamyl arm, shows the lowest K (Hsp90), optimal clogP = 2.82, the best pro-apoptotic properties in SKBR-3 and SKOV-3 and the best selectivity indices (SI). For the most potent GDM derivatives with C(17)-triazole arm, the docking studies have suggested the importance of the intermolecular stabilization between the arm and the D57 or Y61 of Hsp90.

摘要

通过点击化学 CuAAC 将格尔德霉素(GDM)的炔烃(1)和叠氮化物(2)衍生物官能化,得到了 35 个具有不同性质(碱性与酸性、亲水性与疏水性)帽的 C(17)-三唑臂的新同系物(3-37)。将生物数据(抗癌活性与正常细胞毒性)与亲脂性(clogP)、与 Hsp90 形成复合物的离解常数(K)和与 Hsp90 的结合模式进行对比,揭示了 GDM 衍生物特定亚组中的 SAR。具有 C(17)-三唑-苄基-卤代臂的最有效 GDM 同系物 14-16 的 clogP 值最理想,为 2.7-3.1,与 Hsp90 的结合性良好(K 值在 μM 水平)。在 SKBR-3、SKOV-3 和 PC-3 细胞系中,14-16(IC=0.23-0.41 μM)的抗癌活性高于 GDM(IC=0.58-0.64 μM)和放线菌素 D(ActD,IC=0.62-0.71 μM),在健康细胞中具有相当的细胞毒性。具有 C(17)-三唑-糖或 C(17)-三唑-不饱和臂的同系物也表现出结构与吸引力抗癌功效(IC=0.53-0.74 μM)之间的关系。在前一种情况下,C(4)处的绝对构型(ᴅ-葡萄糖与ᴅ-半乳糖),而在后一种情况下,不饱和臂的长度由于与 Hsp90 的不同结合强度(K、ΔE)和模式而影响细胞毒性作用。在所有具有生物吸引力且比 GDM 和 ActD 毒性更低的 GDM 三唑同系物中,具有 C(17)-三唑-肉桂基臂的衍生物 22 显示出最低的 K(Hsp90)、最佳 clogP=2.82、在 SKBR-3 和 SKOV-3 中最佳的促凋亡特性和最佳的选择性指数(SI)。对于具有 C(17)-三唑臂的最有效 GDM 衍生物,对接研究表明臂与 Hsp90 的 D57 或 Y61 之间的分子间稳定的重要性。

相似文献

1
Modifications of geldanamycin via CuAAC altering affinity to chaperone protein Hsp90 and cytotoxicity.通过铜催化的点击化学反应修饰格尔德霉素,改变其与伴侣蛋白热休克蛋白 90 的亲和力和细胞毒性。
Eur J Med Chem. 2023 Aug 5;256:115450. doi: 10.1016/j.ejmech.2023.115450. Epub 2023 May 12.
2
Synthesis, structure and anticancer activity of new geldanamycin amine analogs containing C(17)- or C(20)- flexible and rigid arms as well as closed or open ansa-bridges.新型格尔德霉素胺类似物的合成、结构与抗癌活性,其包含 C(17)-或 C(20)-柔性和刚性臂以及闭合或开环ansa-桥。
Eur J Med Chem. 2020 Sep 15;202:112624. doi: 10.1016/j.ejmech.2020.112624. Epub 2020 Jul 3.
3
Anticancer activity and toxicity of new quaternary ammonium geldanamycin derivative salts and their mixtures with potentiators.新型季铵格尔德霉素衍生物盐及其与增效剂混合物的抗癌活性和毒性。
J Enzyme Inhib Med Chem. 2021 Dec;36(1):1898-1904. doi: 10.1080/14756366.2021.1960829.
4
Potent cytotoxic C-11 modified geldanamycin analogues.强效细胞毒性C-11修饰的格尔德霉素类似物。
J Med Chem. 2009 May 28;52(10):3265-73. doi: 10.1021/jm900098v.
5
7-Chloroquinolinotriazoles: synthesis by the azide-alkyne cycloaddition click chemistry, antimalarial activity, cytotoxicity and SAR studies.7-氯喹啉并三唑类化合物:通过叠氮-炔环加成点击化学合成、抗疟活性、细胞毒性和 SAR 研究。
Eur J Med Chem. 2014 Feb 12;73:295-309. doi: 10.1016/j.ejmech.2013.11.022. Epub 2013 Dec 1.
6
A Novel Series of N-aryltriazole and N-acridinyltriazole Hybrids as Potential Anticancer Agents.新型N-芳基三唑和N-吖啶基三唑杂化物系列作为潜在抗癌剂
Curr Org Synth. 2019;16(6):900-912. doi: 10.2174/1570179416666190704112904.
7
Discovery and development of heat shock protein 90 inhibitors as anticancer agents: a review of patented potent geldanamycin derivatives.热休克蛋白 90 抑制剂作为抗癌药物的发现和开发:专利强效格尔德霉素衍生物的综述。
Expert Opin Ther Pat. 2013 Aug;23(8):919-43. doi: 10.1517/13543776.2013.780597. Epub 2013 May 4.
8
Dimeric and trimeric triazole based molecules as a new class of Hsp90 molecular chaperone inhibitors.基于二聚体和三聚体三唑的分子作为新型 HSP90 分子伴侣抑制剂。
Eur J Med Chem. 2013 Jul;65:464-76. doi: 10.1016/j.ejmech.2013.05.016. Epub 2013 May 23.
9
Synthesis, Antibacterial, and Anticancer Evaluation of Novel Spiramycin-Like Conjugates Containing C(5) Triazole Arm.含C(5)三唑臂的新型螺旋霉素类似物的合成、抗菌及抗癌活性评价
J Med Chem. 2016 Sep 8;59(17):7963-73. doi: 10.1021/acs.jmedchem.6b00764. Epub 2016 Aug 19.
10
A convergent synthesis of novel alkyne-azide cycloaddition congeners of betulinic acid as potent cytotoxic agent.桦木酸新型炔基-叠氮环加成类似物作为强效细胞毒剂的汇聚合成。
Steroids. 2017 Jul;123:1-12. doi: 10.1016/j.steroids.2017.04.002. Epub 2017 Apr 21.

引用本文的文献

1
Geldanamycins: Potent Hsp90 Inhibitors with Significant Potential in Cancer Therapy.格尔德霉素:具有显著癌症治疗潜力的强效 HSP90 抑制剂。
Int J Mol Sci. 2024 Oct 20;25(20):11293. doi: 10.3390/ijms252011293.
2
Geldanamycin, a Naturally Occurring Inhibitor of Hsp90 and a Lead Compound for Medicinal Chemistry.格尔德霉素,一种天然存在的 HSP90 抑制剂,也是药物化学的先导化合物。
J Med Chem. 2024 Oct 24;67(20):17946-17963. doi: 10.1021/acs.jmedchem.4c01048. Epub 2024 Oct 3.
3
Click Chemistry: Reaction Rates and Their Suitability for Biomedical Applications.
点击化学:反应速率及其在生物医学中的适用性。
Bioconjug Chem. 2024 Jun 19;35(6):715-731. doi: 10.1021/acs.bioconjchem.4c00084. Epub 2024 May 22.